Bank of America’s Abiomed Inc ABMD Stock Holding History

Bank of America’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-27,000	Closed	-$4.61M	–	7399
2019 Q4	$4.61M	Hold	27,000	–	–	﹤0.01%	3314
2019 Q3	$4.8M	Buy	27,000 +18,000	+200%	+$3.89M	﹤0.01%	3258
2019 Q2	$2.34M	Hold	9,000	–	–	﹤0.01%	3915
2019 Q1	$2.57M	Buy	+9,000	New	+$2.99M	﹤0.01%	3781

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of America's ABMD Position: Q4 2022 in Review

Bank of America sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 209,427 shares — an estimated $51.4M sold.

Bank of America first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $75.6M in Q3 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Bank of America reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Bank of America sold 209,427 Abiomed Inc shares in Q4 2022, an estimated $51.4M.
Bank of America first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
Bank of America's Abiomed Inc position peaked at $75.6M in Q3 2021.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.